A leading US-based healthcare company, Cardinal Health, has acquired AdaptHealth's diabetes unit for £183M. The deal, which was announced on 20 July 2026, is expected to expand Cardinal Health's diabetes care services in the UK. AdaptHealth will continue to operate independently in the US, providing home healthcare and respiratory services to patients.
According to a statement from AdaptHealth, the sale of its diabetes unit will enable the company to focus on its core business in the US. The company has been expanding its services in the US market and has seen significant growth in recent years. The sale of the diabetes unit is expected to have a minimal impact on AdaptHealth's operations in the US.
Cardinal Health, on the other hand, has stated that the acquisition will enhance its diabetes care services in the UK and provide better access to care for patients. The company has a strong presence in the UK healthcare market and has been investing heavily in its services and infrastructure. The acquisition is expected to be completed in the coming weeks.
The UK's National Health Service (NHS) has been working to improve diabetes care services for patients. The NHS has set targets to reduce diabetes-related complications and improve patient outcomes. The acquisition by Cardinal Health is expected to contribute to these efforts and provide better care for patients with diabetes in the UK.
According to the NHS, diabetes is a significant health concern in the UK, with over 4 million people living with the condition. The NHS has been investing in diabetes care services and has established specialist clinics and services to provide better care for patients. The acquisition by Cardinal Health is expected to support these efforts and provide better access to care for patients with diabetes.
The acquisition is the latest in a series of deals in the UK healthcare sector. The sector has seen significant investment in recent years, with companies looking to expand their services and improve patient care. The UK government has also been investing in the healthcare sector, with a focus on improving patient outcomes and reducing healthcare costs.